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Summary 1 
The inability to talk does not diminish an animal’s ability to experience pain, though it may 2 
hinder the recognition and therefore lead to the under-treatment of pain.  Pain assessment and 3 
treatment in horses has advanced considerably recently with the publication of numerous 4 
research papers in this area. This review will summarise recent research findings and suggest 5 
how advances in knowledge of peri-operative pain management can be implemented in 6 
equine clinical practice. 7 
 8 
Introduction 9 
Unresolved stress or pain behaviour was recently identified as one of the four priority welfare 10 
challenges facing horses in the UK (Horseman, 2017). It is imperative that equine clinicians 11 
both assess pain in horses presented for veterinary attention and ensure that pain management 12 
protocols are optimised as far as possible for individual horses.  13 
The understanding of the physiology of pain has evolved from the concept of a simple reflex 14 
arc to one that involves many complex interactions at all levels of the peripheral and central 15 
nervous system (Livingston and Chambers, 2000). Acute pain usually results from a specific 16 
injury or disease and has a biologic function whereas chronic pain can be considered as a 17 
disease entity in itself  (Lamont et al., 2000). In chronic pain synaptic plasticity of the central 18 
nervous system results in increased  transmission of pain  and a reduction in pain thresholds 19 
at the site of original injury and also areas distant to it (Ji et al., 2003). The difference pain 20 
and nociception is relevant when evaluating results of clinical and experimental studies 21 
investigating analgesics. Pain is defined by the International Association for the Study of Pain 22 
(IASP) as “An unpleasant sensory and emotional experience associated with actual or 23 
potential tissue damage, or described in terms of such damage” ( https://www.iasp-24 
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pain.org/Taxonomy). Measuring pain in animals is challenging so studies often measure 25 
nociceptive responses using electrical, mechanical or thermal stimuli (Moens et al., 2003) 26 
Nociceptive threshold testing is a useful technique but does not replicate the complete pain 27 
experience that is seen in clinical cases and this disparity can lead to differences in response 28 
to a drug in an animal presenting with clinical pain compared to an experimental  model.  29 
The treatment of pain is dependent upon the recognition of pain. Horses in pain may show 30 
“‘low’ and/or ‘asymmetrical’ ears, an angled appearance of the eyes, a withdrawn and/or 31 
tense stare, mediolaterally dilated nostrils and tension of the lips, chin and certain facial 32 
muscles”  (Gleerup et al., 2015) along with changes in behaviour (Price et al., 2003). 33 
Generalised behavioural changes occur regardless of the type of pain stimulus, but these are 34 
often accompanied by more specific localising pain behaviours or physiological changes 35 
(Gleerup and Lindegaard, 2016). An increase in composite pain scale (CPS) and horse 36 
grimace scale (HGS) has been seen in ponies following castration (Dalla Costa et al., 2014), 37 
with similar results following arthroscopic surgery (Price et al., 2003). An association 38 
between CPS score and survival without complication has been found in horses after 39 
emergency gastrointestinal surgery (van Loon et al., 2014).  40 
A  review on the recognition and quantification of pain in horses along with a practical guide 41 
to the implementation of pain assessment protocols in horses was recently published in this 42 
journal and should be consulted for an in depth discussion of this topic (Gleerup and 43 
Lindegaard, 2016). 44 
The finding that surgery is painful is unsurprising, yet in 2005 only 36.9% of UK equine vets 45 
provided analgesia following castration (Price et al., 2005). Hopefully, with increasing 46 
awareness of equine pain behaviours and more data regarding the use of analgesics in horses 47 
this under-treatment will have improved. The reluctance to use analgesics is not limited to the 48 
  
UOB Open 
UK. In New Zealand 55% of veterinarians have morphine available for the treatment of 49 
horses, but 13% only use it (Waran et al., 2010). In an international survey of veterinarians 50 
who perform equine anaesthesia 81.2% of respondents used methadone and 77% morphine 51 
“rarely” or “not at all” (Wohlfender et al., 2015). The tendency towards older analgesics is 52 
also highlighted with 69% of equine vets using Phenylbutazone or Flunixin either “as 53 
standard” or “frequently” (Wohlfender et al., 2015), with 95% of UK equine veterinary 54 
surgeons  prescribing Phenylbutazone or Flunixin. This is in contrast to small animal practice 55 
where there is a move towards more recently licenced treatments (Hunt et al., 2015). 56 
An effective perioperative analgesic plan starts before the procedure and should be 57 
appropriate to the diagnosis, planned surgery and duration of expected postoperative 58 
discomfort. Pre-emptive analgesia will result in clinically effective drug concentrations 59 
before surgery begins. An understanding of drug pharmacology and pain pathways is 60 
essential and assists with the formulation of an individualized multimodal drug protocol 61 
which targets the pain pathways at multiple levels (Muir, 2010). The theory behind the use of 62 
a multi-modal technique is that lower doses of individual drugs can be used by taking 63 
advantage of  additive and synergistic effects  that certain drugs show when given together 64 
with a consequent reduction in side effects (Lamont, 2008). 65 
Locoregional anaesthesia plays an important role in equine pain management protocols and 66 
should be used with  systemic analgesia whenever possible. 67 
The horse is classified as a food producing animal within the EU, and therefore medicines 68 
mentioned in this article should be prescribed in accordance with BEVA guidelines 69 
(www.beva.org.uk).  Medicines prescribed for competition horses should be checked against 70 
the Equine Prohibited Substance List  (https://inside.fei.org/fei/cleansport/ad-h/prohibited-71 
list). Commonly used analgesic drug doses are listed in Table 1. 72 
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Systemic Analgesics 73 
Alpha-2 adrenoceptor agonists  74 
Alpha-2 adrenoceptor agonists produce sedation by acting on the locus coeruleus in the 75 
brainand analgesic effects via actions on supra- and spinal tissues (Murrell and Hellebrekers, 76 
2005). The antinociceptive properties of the alpha-2 adrenoceptor agonists have been 77 
demonstrated using both visceral and mechanical pain models (Moens et al., 2003, Muir and 78 
Robertson, 1985). However, in clinical cases their sedative effects can confound the 79 
interpretation of their analgesic effects, particularly as the sedative effects  outlast the 80 
analgesic properties (Chambers et al., 1993). Increased alpha-2 adrenoceptor selectivity 81 
should theoretically lead to increased analgesic efficacy, especially as alpha-1 adrenoceptor 82 
agonist activity has been found to interfere with alpha-2 adrenoceptor mediated analgesia (Gil 83 
et al., 2009). The alpha-1:alpha-2 selectivity is 1:160 for xylazine, 1:260 for detomidine, 84 
1:360 for romifidine and 1:1620 for (dex-) medetomidine (Sinclair, 2003, Scheinin et al., 85 
1989). Other mechanisms of analgesia may play a role as the in vivo analgesia does not 86 
precisely follow the increasing alpha-2 adrenoceptor selectivity, with detomidine providing 87 
better analgesia than romifidine against electrical stimulation of cutaneous regions (Moens et 88 
al., 2003). This finding may not translate precisely to clinical manifestation of pain (Hamm et 89 
al., 1995, Moens et al., 2003).  90 
Constant rate infusions of alpha-2 adrenoceptor agonists are commonly used for sedation in 91 
standing horses and to supplement inhalant anaesthetic techniques (partial intravenous 92 
anaesthesia).  Following an initial loading dose the aim is to administer the drug by infusion 93 
to achieve stable plasma drug concentrations. This should avoid peaks and troughs in 94 
analgesia or sedation and potentially lead to fewer side effects. The pharmacokinetic profile 95 
of (dex-) medetomidine makes it a good choice for intraoperative continuous rate infusion 96 
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(CRI) (Bettschart-Wolfensberger et al., 1999)., A significant reduction in isoflurane 97 
requirement is seen with medetomidine CRI (K Neges et al., 2003), and dexmedetomidine is 98 
associated with improved recovery scores with only limited cardiopulmonary effects 99 
(Marcilla et al., 2012). The use of a CRI of an alpha-2 adrenoceptor agonist results in a 100 
subjectively more stable plane of anaesthesia and less requirement for additional anaesthetic 101 
top-ups (K Neges et al., 2003) although it is not clear whether this is a result of their 102 
antinociceptive effects or as a consequence of MAC reduction. Dexmedetomidine or 103 
medetomidine do not have a Marketing Authorisation for administration to horses making 104 
their routine use difficult to justify. Romifidine and detomidine are licensed alternatives and 105 
also have an isoflurane-sparing effect (del Barrio 2017). 106 
Although the alpha-2 adrenoceptor agonists lead to a reduction in intestinal motility the 107 
precise effect of an intraoperative CRI on postoperative gastrointestinal function is not clear 108 
and their effects on postoperative analgesia requirements have not yet been established. Their 109 
use may contribute to a multimodal protocol but they should not be relied upon as the sole 110 
analgesic. 111 
Ketamine 112 
Ketamine is a phencyclidine derivative and is the most commonly used agent for the 113 
induction of general anaesthesia horses (Wohlfender et al., 2015). Sub-anaesthetic doses 114 
produce analgesia by interacting with NMDA receptors. In chronic pain states NMDA 115 
receptor antagonism limits the development of central sensitisation by inhibiting temporal 116 
summation and secondary mechanical hyperalgesia (Woolf, 2011). Ketamine is commonly 117 
presented as a racemic mixture of the R(-) and S(+) enantiomers though enantiopure 118 
preparations containing the S(+) isomer are available. S(+)-Ketamine is twice as potent as the 119 
racemic mixture and is associated with faster recovery times. These possible benefits have led 120 
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to preliminary investigations into its use in the horse (Canola et al., 2015, Casoni et al., 2015, 121 
Larenza et al., 2009) though this preparation does not have a veterinary Marketing 122 
Authorisation. 123 
In healthy patients, after administration of ketamine direct stimulation of the central nervous 124 
system leads to increased sympathetic tone and subsequent increases in blood pressure and 125 
heart rate. In sick patients the direct depressant effects of ketamine on the myocardium may 126 
become apparent due to depletion of catecholamine stores within the sympathetic system. A 127 
MAC sparing effect of 37% was found under halothane anaesthesia when ketamine was 128 
given by CRI whilst increasing cardiac output (Muir and Sams, 1992). Low dose ketamine 129 
infusion (20 mcg/kg/min) in conscious experimental horses reduces the response to electrical 130 
cutaneous stimulation (Peterbauer et al., 2008).  The same can be found in clinical cases; 131 
horses with naturally occurring laminitis that received 0.6mg/kg/hr ketamine for six hours 132 
once daily for three days, alongside tramadol twice daily, had increased forelimb loading 133 
both during and after treatment and this was attributed to ketamine’s effect on central 134 
sensitization (Guedes et al., 2012). The same laminitic horses also had lower concentrations 135 
of circulating inflammatory prostaglandins TNF-α and thromboxane B(2) indicating an anti-136 
inflammatory effect of systemic ketamine use. Clinical experience suggests that a low dose 137 
ketamine CRI may have some benefit in cases that involve orthopaedic and integument pain 138 
that is not responding to conventional treatment with opioids and NSAIDs, though it may be 139 
of less use in visceral pain (Matthews et al., 2004). 140 
Opioids 141 
Opioids, particularly butorphanol, are often included in sedation protocols though 142 
perioperative use of opioids is still limited in equine practice (Wohlfender et al., 2015). This 143 
may be related to apprehension over possible side effects, with the potential for excitability 144 
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following intravenous injection and decreased intestinal motility following general 145 
anaesthesia being commonly stated concerns (Clutton, 2010). 146 
Horses that received a morphine bolus followed by a CRI during halothane anaesthesia had 147 
similar haemodynamic variables to those that did not (Clark et al., 2005)and the 148 
administration of  morphine was also associated with the need for less additional anaesthetic 149 
agent, fewer attempts to stand and shorter times to standing (Clark et al., 2005, Clark et al., 150 
2008, Love et al., 2006). The optimal dose of morphine for analgesia in clinical cases has not 151 
yet been established. The early dose-response studies investigated relatively high doses of 152 
morphine in small numbers of pain-free, healthy horses using experimental threshold testing 153 
assays rather than clinical pain (Kalpravidh et al., 1984b, Roger et al., 1985).(Kalpravidh et 154 
al., 1984b).  In horses undergoing airway surgery 0.2 mg/kg bwt had no additional benefits 155 
over 0.1 mg/kg bwt on the duration or quality of recovery following anaesthesia although the 156 
surgery performed was relatively non-invasive (compared to orthopaedic surgery) and post-157 
operative pain was not assessed (Love et al., 2006). Conflicting results on the association of 158 
post anaesthetic colic and the use of morphine may lead to difficulties when deciding on its 159 
use. In one retrospective study the use of morphine was associated with a four-fold increase 160 
in the risk of colic following orthopaedic surgery (Senior et al., 2004), however another 161 
retrospective study found no increased incidence of post anaesthetic colic in horses that 162 
received morphine compared to those that did not (Andersen et al., 2006). Morphine is 163 
associated with an increase in locomotor activity in healthy pain free horses (Carregaro et al., 164 
2007). This increase in locomotor activity is less likely to be seen in horses having surgery or 165 
those that are already experiencing pain (Mircica et al., 2003, Muir, 1981), with horses that 166 
received 0.1 mg/kg bwt morphine for sedation for standing surgery showing no intraoperative 167 
ataxia or locomotor activity (Potter et al., 2016). The conflicting arguments presented above 168 
highlight the different findings that may be seen in experimental and clinical studies and 169 
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explain why the use of systemic morphine in horses is controversial. More data is available to 170 
support the use of morphine by the epidural or intraarticular routes in horses. 171 
Buprenorphine has a marketing authorisation in the UK for postoperative analgesia in horses. 172 
It produces antinociception to thermal stimuli (Love et al 2012) and these experimental 173 
findings were provided more effective postoperative analgesia than butorphanol after elective 174 
surgical procedures performed under general anaesthesia without detrimental effects ( Taylor 175 
et al., 2016, , . The use of buprenorphine in combination with Detomidine via CRI for 176 
standing surgery resulted in more complications than the use of morphine (Potter et al., 177 
2016). All horses that received buprenorphine showed box walking and tremors/shivering, 178 
half of the horses were hypersensitive to noise in the postoperative period. No horses that 179 
received morphine showed complications, though only a small sample size of four horses per 180 
group was used. This increased incidence of side effects in the buprenorphine group may be 181 
due to the effect that detomidine has on the excretion of drugs administered at the same time 182 
resulting in a higher plasma concentration than that achieved when buprenorphine is given 183 
alone (Pakkanen et al., 2015). In order to investigate this hypothesis plasma samples would 184 
have needed to be taken for buprenorphine concentration determination. In addition local 185 
anaesthetic blocks were used as part of the analgesic protocol – if these were effective the 186 
requirements for buprenorphine would have been reduced. Sublingual use of buprenorphine 187 
has been reported in a five month old thoroughbred filly with a cervical vertebral fracture 188 
(Walker, 2007). A dose of 0.006 mg/kg bwt was given twice daily with onset of analgesia 189 
and sedation subjectively assessed to occur 45 minutes after administration into the 190 
interdental space. Mucosal absorption of buprenorphine following sublingual administration 191 
may provide a practically easy method of providing longer duration postoperative analgesia. 192 
Butorphanol is the most commonly used opioid in equine practice (Wohlfender et al., 2015). 193 
In nociceptive studies of visceral and superficial pain 0.2 mg/kg bwt was suggested as the 194 
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optimal dose (Kalpravidh et al., 1984a). The duration of analgesia for visceral pain was 4 195 
hours after 0.22 mg/kg bwt, compared to 1 hour of visceral analgesia after 0.66 mg/kg bwt 196 
morphine (Kalpravidh et al., 1984b). Despite this, no improvement in recovery quality or a 197 
reduction in inhalational requirement has been seen during anaesthesia (Bettschart-198 
Wolfensberger et al., 2011, Dias et al., 2014). Postoperative CRI of butorphanol at 13 199 
mg/kg/hr was associated with lower plasma cortisol concentrations, improved behaviour 200 
scores and less bodyweight loss (Sellon et al., 2004). This finding is consistent with the 201 
horses receiving butorphanol CRI postoperative experiencing less pain. It has been 202 
demonstrated to be an ineffective sole analgesic following castration (Love et al., 2009).   203 
Methadone has a UK Marketing Authorisation for use in cats and dogs. A dose of 0.2 mg/kg 204 
bwt has been demonstrated to have an antinociceptive effect to mechanical, thermal and 205 
electrical stimulus when administered in combination with acepromazine or detomidine to 206 
horses, with the combination of methadone and detomidine having the greatest effect (Lopes 207 
et al., 2016). In a lipopolysaccharide induced synovitis model methadone was found to 208 
produce analgesia with less reduction in gastrointestinal sounds than morphine (Carregaro et 209 
al., 2014). If this finding is found to be consistent in clinical cases this may alleviate some of 210 
the concerns of postoperative ileus after morphine. Studies on the analgesic effect of 211 
methadone on animals experiencing clinical pain are currently limited.  212 
Transdermal fentanyl patches have been used to treat horses with pain non-responsive to 213 
NSAID treatment, application of either one or two 10mg fentanyl patches to the 214 
antebrachium was found to reduce pain but not lameness scores. Uptake of drug is varies 215 
between sites of application; the thorax or groin results in greater systemic absorption with 216 
shorter lag time than the limb (Mills and Cross, 2007). The method used to prepare the area 217 
for transdermal drug administration has an effect on the systemic absorption as does variation 218 
in skin thickness between sites (Mills and Cross, 2006, Mills et al., 2004). The time taken to 219 
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reach analgesic serum concentrations varies from 1 to 14 hours (Thomasy et al., 2004, 220 
Maxwell et al., 2003), and in one study plasma concentrations of fentanyl failed to reach 221 
analgesic levels in 33% of horses (Orsini et al., 2006). Transdermal patches were found to be 222 
easy to apply and well tolerated in foals, but similar to adults systemic absorption was 223 
variable with no assessment of analgesic provision (Eberspacher et al., 2008). Based on the 224 
studies when placing a transdermal fentanyl patch the skin should be clipped and prepared 225 
with alcohol and chlorhexidine soloution (Mills and Cross, 2006). The most appropriate site 226 
to apply the patch is the thorax. Due to impracticalities of keeping the patch in position use of 227 
a limb is better suited for keeping the patch in contact with the skin. The variable lag time 228 
and systemic absorption means that the use of transdermal fentanyl patches requires close 229 
attention to the monitoring of pain scores, but may be useful for long lasting analgesia of 230 
outpatients postoperatively.   231 
Lidocaine 232 
Lidocaine is often used systemically for its prokinetic properties in horses with colic, its 233 
analgesic properties have also been shown in horses undergoing castration (Murrell et al., 234 
2005), and its use is associated with a reduction in the use of inhalational agents (Schuhbeck 235 
et al., 2012). Its use in standing horses resulted in analgesia to a thermal stimulus but not to 236 
colorectal distension, suggesting a possible role in managing somatic pain (Robertson et al., 237 
2005).  238 
The potential for adverse effects should be considered when lidocaine is used systemically, 239 
neurological signs of toxicity include rapid blinking, anxiety, visual disturbance and ataxia 240 
and may be seen at doses of 30 µg/kg/min (Meyer et al., 2001). Horses that had a 1.5 mg/kg 241 
bwt loading bolus developed clinical signs earlier than those horses that did not, with 242 
cardiovascular signs of toxicity not apparent at doses causing neurological signs. The 243 
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systemic dose needed to produce toxic side effects may be reduced in compromised patients 244 
due to a slower hepatic clearance of the drug. General anaesthesia may make recognition of 245 
toxicity harder. A bolus of lidocaine before CRI is often used, but this may not be required as 246 
no inhalant sparing effect or difference in cardiopulmonary parameters and recovery scores 247 
was found between horses that did or did not receive a loading bolus whilst under isoflurane 248 
anaesthesia (Nannarone et al., 2015). Not giving a loading bolus may reduce the potential for 249 
reaching a toxic threshold.  250 
Intraoperative administration of lidocaine may have a negative impact on quality of recovery 251 
from general anaesthesia (Schuhbeck et al., 2012, Valverde et al., 2005) so it is recommended 252 
that the lidocaine CRI should be stopped at least 30 minutes before transfer to the recovery 253 
box and also that additional sedation in recovery may be required (Valverde et al., 2005). 254 
One study supports the therapeutic role of lidocaine in horses with ileus by reduction in 255 
reflux and shorter length of hospitalisation (Malone et al., 2006), however a more recent 256 
study found no effect of lidocaine administration on total reflux volume or duration, or on 257 
postoperative survival (Salem et al., 2016). Equivocal results on its use for analgesia and 258 
reduction of postoperative ileus mean that lidocaine should not be relied upon to provide 259 
post-operative analgesia and other analgesics should be administered concurrently.  260 
Non-Steroidal Anti Inflammatory Drugs  261 
NSAIDs remain the mainstay of analgesia in horses and, unless there is a contra-indication to 262 
their administration, should be included in the analgesic protocols of horses undergoing 263 
surgery . The variety of formulations and their long duration of action make them an 264 
attractive choice, with phenylbutazone and flunixin the most commonly used drugs 265 
(Wohlfender et al., 2015, Price et al., 2002). Clinical experience and familiarity probably 266 
form the basis of NSAID selection in clinical practice. Clinicians often express a preference 267 
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for the use of Phenylbutazone in horses with orthopaedic pain and Flunixin for horses with 268 
visceral pain, though this is not supported by the evidence (Johnson et al., 1993). Pre-emptive 269 
administration of NSAIDs may also help to reduce the likelihood of development of central 270 
sensitisation as has been shown with opioid and NSAID administration in other species 271 
(Lascelles et al., 1998, Lascelles et al., 1997) and timing their administration so that they are 272 
given before surgery means that they will be having an analgesic effect when the effects of 273 
anaesthesia are waning. 274 
NSAIDs act by inhibition of cyclo-oxygenase (COX-1 and -2) enzymes, resulting in a 275 
reduction in the production of prostaglandins and thromboxane. COX-2 selectivity was 276 
thought to be preferential with COX-1 being a constitutive enzyme required for coagulation, 277 
protection of gastric mucosa and maintenance of renal blood flow. It is now known that 278 
COX-2 is also a constitutive enzyme in the eye, central nervous system and kidney, with 279 
COX-2 required for the healing of gastric ulcers. Potential adverse effects reported for 280 
NSAID use at therapeutic doses in the horse include gastric ulceration, renal dysfunction and 281 
right dorsal colitis (Andrews and McConnico, 2009).  282 
Meloxicam is a COX-2 selective NSAID that is licenced for the treatment of acute and 283 
chronic musculoskeletal disorders and colic. Evidence also exists to suggest a beneficial 284 
effect on healing of the intestinal mucosa following ischaemic injury when meloxicam is 285 
used (Little et al., 2007). When compared to flunixin for provision of postoperative analgesia 286 
following surgery for strangulating small intestine, meloxicam showed no difference in 287 
analgesia based upon clinical evaluation, however when pain scores were compared horses 288 
that received flunixin had significantly lower scores (Naylor et al., 2014)..  289 
Firocoxib is licenced for the treatment of pain associated with osteoarthritis, and vedaprofen 290 
for the treatment of postoperative pain. Firocoxib has shown to work as well as both 291 
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Phenylbutazone and Vedaprofen for treatment of osteoarthritis without treatment related side 292 
effects (Doucet et al., 2008, Koene et al., 2010).  293 
The use of topical NSAID creams and gels is reported clinically, with a cream containing 1% 294 
diclofenac sodium available outside the UK. There is a lack of evidence to support the 295 
clinical use of these preparations.   296 
Other Systemic Analgesics 297 
The use of gabapentin is documented in case reports for the treatment of neuropathic pain 298 
unresponsive to other treatments (Davis et al., 2007), and management of severe hoof pain in 299 
combination with other systemic analgesics (Dutton et al., 2009). Tramadol co-administered 300 
with a low dose of ketamine was successfully used as part of an analgesic protocol in a horse 301 
with pain due to laminitis (Guedes et al., 2012). Tramadol 5mg/kg bwt orally every 12 hours 302 
for 1 week gave limited analgesia for three days only. The addition of a ketamine infusion at 303 
0.6 mg/kg/hr, for 6 hours on the first three days of treatment, significantly increased the level 304 
and duration of analgesia. An experimental study reported a lack of anti-nociceptive effects  305 
against thermal, electrical or pinprick stimulation following administration of tramadol at 2 306 
mg/kg bwt i.v. (Dhanjal et al., 2009, Seo et al., 2011) although the duration of antinociception 307 
following xylazine administration was extended by the concurrent use of tramadol (Seo et al., 308 
2011) suggesting that it may play a useful role as part of a multimodal analgesic protocol. 309 
The use of paracetamol as an adjunct treatment for laminitis has also been described in a 310 
pony (West et al., 2011). Further research is needed before routine use of these drugs can be 311 
recommended although their use can be considered on an individual case basis. 312 
Locoregional Techniques 313 
Local Anaesthesia 314 
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The use of local anaesthetics for the diagnosis of lameness in horses is commonplace; the 315 
same techniques and drugs can also be used for the provision of effective perioperative 316 
analgesia. The versatility of this class of drug means that it can be used in multiple different 317 
ways, with a technique available for most situations. Local anaesthetics stop the transmission 318 
of the pain signal by binding to and blocking Na+ channels when they are in the open or 319 
inactivated state, for this reason nerves of high firing frequency are most likely to be blocked. 320 
One limitation of the local anaesthetics is their reduced performance in infected tissues, this 321 
is due to the altered pH of the tissue affecting the fraction of unionised drug (Ueno et al., 322 
2008). In this instance a nerve block at a site remote from the infected tissue may be of 323 
benefit. 324 
The use of nerve blocks to facilitate dental and ophthalmic procedures in the standing and 325 
anaesthetised horse is well described. The inferior alveolar (mandibular) block will 326 
desensitise the mandible and lower dental arcade (Harding et al., 2012) and the maxillary 327 
block desensitises most structures of the maxilla including the rostral maxilla, paranasal 328 
sinuses and upper dental arcade (Bardell et al., 2010).  Accidental blockade of the lingual 329 
nerve has been reported to occur with blockade of the mandibular nerve resulting in self 330 
trauma of the tongue (Caldwell and Easley, 2012).  When performing nerve blocks of the 331 
horse’s eye it should be remembered that the auriculopalpebral/palpebral nerve supplies only 332 
motor function and, although a block of this nerve will aid in examination of the eye, it does 333 
not desensitise any structures. Blockade of the frontal, lacrimal, zygomatic and infratrochlear 334 
nerves will desensitise the periorbital region. A retrobulbar block will facilitate enucleation, 335 
but may need to be accompanied by an auriculopalpebral block for immobilising the upper 336 
eyelid.  337 
Infiltration of local anaesthetic into the testicle, cord and subcutaneously before castration in 338 
standing, sedated horses is routine; this technique is also useful in anaesthetised horses and 339 
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may reduce the incidence of movement as well as requirement for supplemental doses of 340 
anaesthetics  (Portier et al., 2009). Subcutaneous infiltration of local anaesthetic is easy to 341 
perform before wound closure.  342 
Increasingly, orthopaedic surgery is being performed in standing, sedated horses and nerve 343 
blocks can improve surgical conditions and reduce the requirements for additional chemical 344 
restraint. In standing, sedated horses distal limb blocks should be performed before 345 
arthroscopy or fracture repair, with specific nerve blocks often being used alongside a ring 346 
block (Payne and Compston, 2012). Intravenous regional techniques for delivery of 347 
antimicrobials is commonly implemented in equine practice and the same technique can be 348 
used to desensitise the distal limbs. Desensitization of the limb being operated on with local 349 
anaesthesia can also be considered in horses having the procedures done under general 350 
anaesthesia. Careful thought should be given to the individual case as ataxia and effects on 351 
control of the limb are potential hazards during recovery from anaesthesia.  352 
Intraarticular injection following arthroscopic procedures can contribute to postoperative 353 
analgesia. Morphine, local anaesthetics and the alpha-2 adrenoceptor agonists all provide 354 
analgesia for inflamed joints (van Loon et al., 2010). Caution must be used as systemic 355 
uptake of the drugs still occurs and systemic side effects can still be seen (Di Salvo et al., 356 
2014). Concern over chondrotoxicity of the local anaesthetics has been a topic of discussion 357 
in recent years. In an in vitro cell culture preparation of equine chondrocytes mepivacaine 358 
was the least chondrotoxic, with bupivacaine showing the most chondrotoxicity to equine 359 
cartilage (Park et al., 2011). However, in vivo effects do not always mimic the changes seen 360 
in laboratory cell culture preparations and the method of delivery of the local anaesthetic 361 
probably has a significant impact on the effects of local anaesthetics on chondrocytes since in 362 
people continuous infusion of local anaesthetic into the joint has a more deleterious effect 363 
than would be expected from a drug effect alone (Dragoo et al., 2008). A single injection of a 364 
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low concentration of local anaesthetic would appear to be safe, whereas the effects of a 365 
continuous infusions require further investigation (Webb and Ghosh, 2009).  366 
When morphine (0.05 mg/kg) is given intraarticularly, to horses with lipopolysaccharide 367 
induced synovitis, it is detectable within the synovial fluid for 24 hours and results in less 368 
swelling and lameness than the same dose of morphine given IV (Lindegaard et al., 2010a, 369 
Lindegaard et al., 2010b, Lindegaard et al., 2010c). The reduced swelling of the joint when 370 
morphine was given intraarticularly supports morphine having a peripheral anti-inflammatory 371 
effect as well as a central mechanism of action. Despite a reduction in lameness there was no 372 
difference in pain score between the two routes of administration (Lindegaard et al., 2010c). 373 
Paravertebral thoracolumbar anaesthesia in horses having standing laparoscopic procedures 374 
produces good to excellent anaesthesia in 80% of cases (Moon and Suter, 1993). 375 
Epidural and Subarachnoid Anaesthesia and Analgesia 376 
Epidural anaesthesia was first described in the horse almost 100 years ago (Pape and 377 
Pitzschk, 1925). Use of both a single injection and repeated dosing via an epidural catheter 378 
are options for both intra-operative and post-operative analgesia. Local anaesthetics, opioids 379 
and alpha-2 adrenoceptor agonists can all be administered via the epidural space, though it 380 
must be remembered that systemic uptake of the drugs will occur and side effects of may 381 
become apparent for example, sedation and ataxia Epidural injections are most commonly 382 
performed via the first intercoccygeal space, with location of the space most practically 383 
identified by repeatedly raising and lowering the tail.. Subarachnoid injection, where the drug 384 
is injected into the cerebrospinal fluid rather than the epidural space, can be performed at the 385 
lumbar-sacral (L7-S1) space, though this technique is more challenging and often resented by 386 
the horses (Natalini and Driessen, 2007) which limits its use clinically. 387 
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Opioids, most commonly morphine, are used for epidural analgesia. Opioid receptors are 388 
found extensively in the dorsal horn of the spinal cord, and opioid agonists can provide 389 
effective and long-lasting pain relief (Valverde et al., 1990, Cousins and Mather, 1984). 390 
Analgesia can be achieved as far cranially as the thoracic dermatomes after a single epidural 391 
injection of morphine diluted to a volume of 20mL (Natalini and Robinson, 2000). Another 392 
potential benefit is that morphine administered into the epidural space has also been found to 393 
inhibit the development of hyperalgesia in an experimental model of synovitis (van Loon et 394 
al., 2012). 395 
Concern over side effects is similar when administering opioids in the epidural space as when 396 
they are given systemically although the dose administered epidurally is usually lower that 397 
that given systemically which should reduce the risk or intensity of side effects. In healthy 398 
horses morphine reduced gastrointestinal transit times in healthy horses but not when used for 399 
provision of analgesia for laparoscopic castration (Sano et al., 2011, Martin-Flores et al., 400 
2014) indicating differences in effects between healthy and painful horses. 401 
Both methadone and buprenorphine also provide effective analgesia when given epidurally.  402 
Methadone provides effective analgesia but with a shorter duration than that reported for 403 
morphine (Olbrich and Mosing, 2003). In horses undergoing bilateral stifle arthroscopy 404 
epidural buprenorphine plus detomidine produced analgesia of similar intensity and duration 405 
to that provided by morphine and detomidine (Fischer et al., 2009). 406 
Combining a local anaesthetic with an opioid extends the duration of analgesia compared to 407 
the use of an opioid alone (Hendrix et al., 1996). However, care should be taken with the 408 
volume of local anaesthetic used as cranial spread can impair the function of the pelvic limbs 409 
and cause ataxia or even paralysis. If an epidural including a local anaesthetic is to be 410 
administered consider restraining the horse in stocks and ensure that everyone working with 411 
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the horse is aware that ataxia is a potential risk. The total volume used will depend on the size 412 
and conformation of the horse and the drug or combination of drugs used. Less than 10mL 413 
total volume should be used in adult horses if a combination including a local anaesthetic is 414 
used, as cranial spread of volumes greater than this may cause hindlimb paralysis and 415 
recumbency of the patient (Natalini and Driessen, 2007).  416 
Alpha-2 adrenoceptor agonists administered epidurally can increase both the sensory and 417 
motor blockade compared to an opioid or local anaesthetic used alone. Speed of onset is 418 
quicker and an extended duration of action is also seen (Grubb et al., 1992). Doses of other 419 
drugs given at the same time should be reduced. Systemic uptake of the drug also occurs and 420 
signs of sedation, ataxia and cardiovascular changes such as bradycardia and atrioventricular 421 
block may become apparent. 422 
Adjunctive Therapies 423 
When devising a perioperative analgesia plan the use of non-drug therapy should also be 424 
considered. Good nursing care is imperative and in addition the use of cold packs on inflamed 425 
tissues and physiotherapy when appropriate will also help. Although acupuncture is 426 
frequently employed by equine veterinarians in the treatment of chronic pain (Bergenstrahle 427 
and Nielsen, 2016) its efficacy for treatment of acute pain and in the perioperative period is 428 
unknown. Its use for the treatment of colic pain has been shown to be less effective than 429 
butorphanol in one method (Skarda and Muir, 2003) and ineffective in another (Merritt et al., 430 
2002).  431 
Conclusion 432 
The ability to recognise pain behaviours in horses is an essential skill of the equine 433 
veterinarian. The publication of clinically useful pain scales for this species will further aid in 434 
the recognition of pain in the perioperative period. Careful consideration should be given to 435 
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the mechanism of the pain stimulus when planning a surgery and an analgesic plan. Table 2 436 
suggests when each therapy should be used. The use of multimodal analgesia utilising drugs 437 
from different classes and given both systemically and locoregionally will improve outcomes 438 
and the welfare of patients.   439 
  440 
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